Theravance - THRX Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Theravance - THRX

THRX 9.810

+0.4%

Jan 8 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: IRWIN JAMES FRANKEL who wrote (26)	8/22/2006 8:06:43 PM
From: Robohogs	of 74

My bad - I was just waking up and agree. And if they can get the p stats in the label, they will get the mkting advantage as most docs probably don't care if it is .048 or .053, etc. I do think uptake could be modest here though as public interest is maybe best served by using this drug as second or third line after failures - isn't that what the hospitals typically do to reduce resistance to the strongest antiobiotics? All in all good news but not great, great! Jon

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next